Livzon Pharmaceutical Group Inc (000513):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Livzon Pharmaceutical Group Inc (000513) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3459
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥34,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥69,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥103,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Livzon Pharmaceutical Group Inc (Livzon), a subsidiary of Joincare Pharmaceutical Group Industry Co Ltd, is a pharmaceutical company which is engaged in developing, manufacturing and distributing pharmaceutical products. The company provides preparation drug products, bulk medicines and intermediates, and diagnostic reagents and equipment. Its products include menotropins injection, urofollitropin injection, perospirone hydrochloride tablets, and ranitidine bismuth citrate tablets, among others. Livzon offers diagnostic kits such as BV quick-test kit, anti-HCV rapid test, anti-HAV IgM ELISA kit, anti-TOXO IgG ELISA and HBsAg ELISA kit. The company offers drugs for various therapeutic areas such as antibiotics, antibacterial, gastrointestinal, psychotropic, antiviral, immunomodulation, anti-allergic and traditional Chinese medicine. It operates through its production facility located in Shanxi, Gansu and Yunan, China. Livzon is headquartered in Zhuhai, China.

Livzon Pharmaceutical Group Inc (000513) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Livzon Pharmaceutical Group Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Livzon Pharmaceutical Group Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Livzon Pharmaceutical Group Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Livzon Pharmaceutical Group Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Livzon Pharmaceutical Group Inc, Medical Devices Deals, 2012 to YTD 2018 9
Livzon Pharmaceutical Group Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Livzon Pharmaceutical Group Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Cynvenio Biosystems Raises USD25.5 Million in Series B Equity Financing 11
Partnerships 12
Livzon Pharma Plans to Form Joint Venture in Zhuhai City 12
Equity Offering 13
Livzon Pharma Raises USD230.4 Million in Private Placement of Shares 13
Cynvenio Biosystems Raises USD10 Million in Private Placement of Series B Preferred Shares 14
Acquisition 15
Livzon Pharma to Sell 15% Stake in Livzon Group Xinbeijiang Pharma to Zhuhai Zhong Hui Yuan for USD10.5 Million 15
Livzon Biologics to Acquire Remaining 51% Stake in Livzon MabPharm from Livzon Pharma for USD48.7 Million 16
Livzon Pharma to Sell its Pharma Firm for USD661 Million 17
Livzon Pharmaceutical Group Inc – Key Competitors 18
Livzon Pharmaceutical Group Inc – Key Employees 19
Livzon Pharmaceutical Group Inc – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
Livzon Pharmaceutical Group Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Livzon Pharmaceutical Group Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Livzon Pharmaceutical Group Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Livzon Pharmaceutical Group Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Livzon Pharmaceutical Group Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Livzon Pharmaceutical Group Inc, Medical Devices Deals, 2012 to YTD 2018 9
Livzon Pharmaceutical Group Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Cynvenio Biosystems Raises USD25.5 Million in Series B Equity Financing 11
Livzon Pharma Plans to Form Joint Venture in Zhuhai City 12
Livzon Pharma Raises USD230.4 Million in Private Placement of Shares 13
Cynvenio Biosystems Raises USD10 Million in Private Placement of Series B Preferred Shares 14
Livzon Pharma to Sell 15% Stake in Livzon Group Xinbeijiang Pharma to Zhuhai Zhong Hui Yuan for USD10.5 Million 15
Livzon Biologics to Acquire Remaining 51% Stake in Livzon MabPharm from Livzon Pharma for USD48.7 Million 16
Livzon Pharma to Sell its Pharma Firm for USD661 Million 17
Livzon Pharmaceutical Group Inc, Key Competitors 18
Livzon Pharmaceutical Group Inc, Key Employees 19
Livzon Pharmaceutical Group Inc, Subsidiaries 20

List of Figures
Livzon Pharmaceutical Group Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Livzon Pharmaceutical Group Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Livzon Pharmaceutical Group Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Livzon Pharmaceutical Group Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Livzon Pharmaceutical Group Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Livzon Pharmaceutical Group Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Livzon Pharmaceutical Group Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Livzon Pharmaceutical Group Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Livzon Pharmaceutical Group Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Livzon Pharmaceutical Group Inc (000513):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • NIKE Inc:企業のM&A・事業提携・投資動向
    NIKE Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's NIKE Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital …
  • Vesuvius Plc:企業の戦略・SWOT・財務情報
    Vesuvius Plc - Strategy, SWOT and Corporate Finance Report Summary Vesuvius Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Saudi Arabian Oil Co (2222):企業の財務・戦略的SWOT分析
    Saudi Arabian Oil Co (2222) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • British Columbia Cancer Agency-製薬・医療分野:企業M&A・提携分析
    Summary British Columbia Cancer Agency (BC Cancer Agency), a subsidiary of Provincial Health Services Authority is a healthcare service center that provides comprehensive cancer control program. The center offers services such as patient assessment, diagnostic and therapy planning, radiation therapy …
  • Bunge North America, Inc.:戦略・SWOT・企業財務分析
    Bunge North America, Inc. - Strategy, SWOT and Corporate Finance Report Summary Bunge North America, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Nasser S. Al –Hajri Corp:企業の戦略的SWOT分析
    Nasser S. Al –Hajri Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Air New Zealand Limited:企業の戦略・SWOT・財務情報
    Air New Zealand Limited - Strategy, SWOT and Corporate Finance Report Summary Air New Zealand Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Nucor Corporation:企業のM&A・事業提携・投資動向
    Nucor Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Nucor Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • Encavis AG:企業のM&A・事業提携・投資動向
    Encavis AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Encavis AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capi …
  • Pioneer Natural Resources Co Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Pioneer Natural Resources Co Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Pioneer Natural Resources Co (Pioneer) is an independent oil and natural gas exploration and production company. Its principally operates in Eagle Ford Shale, Permian Basin, Raton Basin, …
  • Exxon Mobil Corp (XOM):企業の財務・戦略的SWOT分析
    Exxon Mobil Corp (XOM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Hochdorf Holding AG (HOCN):企業の財務・戦略的SWOT分析
    Hochdorf Holding AG (HOCN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Freehold Royalties Ltd (FRU):企業の財務・戦略的SWOT分析
    Summary Freehold Royalties Ltd (Freehold Royalties), formerly Freehold Royalty Trust is an oil and gas company that offers oil and gas operation and financial performance. Its oil and gas assets generate income from natural gas, crude oil, natural gas liquids and potash deposits. It provides horizon …
  • MS&AD Insurance Group Holdings, Inc.:企業の戦略・SWOT・財務情報
    MS&AD Insurance Group Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary MS&AD Insurance Group Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Celsense Inc-製薬・医療分野:企業M&A・提携分析
    Summary Celsense Inc (Celsense) is a biotechnology company that develops magnetic resonance imaging detection products. The company’s products include v-sense, cell sense and voxel tracker. Its v-sense product is used to detect a range of lesions and diseases where inflammation is a hallmark such as …
  • Indutrade AB (INDT):企業の財務・戦略的SWOT分析
    Summary Indutrade AB (Indutrade) is an industrial goods company that develops and sells high-tech products and solutions. The company operates through its business divisions such as engineering and equipment, flow technology, measurement and sensor technology, industrial components, and fluids and m …
  • OBI Pharma Inc (4174):企業の財務・戦略的SWOT分析
    Summary OBI Pharma Inc (OBI Pharma) is a biopharmaceutical company that develops therapies for the treatment of cancer and infectious diseases. The company’s products include adagloxad simolenin, an active immunotherapy which is intended for the treatment of metastatic breast cancer; and OBI-833, a …
  • Siltech Corp:企業の戦略的SWOT分析
    Siltech Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Extendicare Inc (EXE):企業の財務・戦略的SWOT分析
    Summary Extendicare Inc (Extendicare), formerly Crownx Inc is a healthcare service provider that offers long-term care services. The center’s services include short stay care, convalescent care, home health care, group purchasing, assisted living, retirement living, workplace health and wellness, sk …
  • Fortis Inc (FTS):石油・ガス:M&Aディール及び事業提携情報
    Summary Fortis Inc (Fortis) is an oil and gas company that provides development of assets and market capitalization programs. The company offers measurement and monitoring of environmental impacts. It also provides capital program and growth plans to meet the energy needs. Fortis support and partici …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆